Most cited papers from Lifecare Innovations (India)
What are the most cited papers from Lifecare Innovations (India)?
The most cited paper from Lifecare Innovations (India) is "A Review on the Stability Challenges of Advanced Biologic Therapeutics" (Sruthi Sarvepalli, Shashank Reddy Pasika, Vartika Verma et al., 2025), with 50 citations. Next come "Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin" (26) and "Nanoformulations of Moxifloxacin, Econozole and Ethionamide as Novel Treatment Regimens Against MDR TB - An Experimental Study" (7).
Showing 4 of 4 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | A Review on the Stability Challenges of Advanced Biologic Therapeutics Sruthi Sarvepalli, Shashank Reddy Pasika, Vartika Verma et al. · Pharmaceutics | 23 Apr 2025 | 50 |
| 2 | Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin Pradip Nirbhavane, Nalini Vemuri, Neeraj Kumar et al. · AAPS PharmSciTech | 27 Jun 2016 | 26 |
| 3 | Nanoformulations of Moxifloxacin, Econozole and Ethionamide as Novel Treatment Regimens Against MDR TB - An Experimental Study Nalini Vemuri, Gopal Krishan Khuller, Tanushree Prabhakar et al. · Current Nanoscience | 3 Sep 2015 | 7 |
| 4 | Improving access to liposomal amphotericin B worldwide Manoj Jadhav, J. Verma, Nilima Arun Kshirsagar · The Lancet Global Health | 18 Dec 2024 | 1 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.